Post-approval studies (Phase 4)UnknownNCT01456312What this trial is testingHBsAg Related Response Guided TherapyWho this might be right forHepatitis B, Chronic Gangnam Severance Hospital 200
Post-approval studies (Phase 4)Study completedNCT00614471What this trial is testingPEGASYS (Peginterferon Alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B.Who this might be right forHepatitis B, Chronic Hoffmann-La Roche 219
Post-approval studies (Phase 4)Study completedNCT01519921What this trial is testingPEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B.Who this might be right forHepatitis B, Chronic Hoffmann-La Roche 150
Not applicableStudy completedNCT01732354What this trial is testingStudy for Consolidation Period of Chronic Hepatitis BWho this might be right forHepatitis B Tainan Municipal Hospital 137
Not applicableStudy completedNCT03546530What this trial is testingThe Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B PatientsWho this might be right forHepatitis BInterferon The First Hospital of Jilin University 228
Not applicableStudy completedNCT01667432What this trial is testingAn Observational Study of Peginterferon Alfa-2a (PEGASYS®) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis BWho this might be right forHepatitis B, Chronic Hoffmann-La Roche 141
Large-scale testing (Phase 3)Ended earlyNCT02058108What this trial is testingStudy of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus InfectionWho this might be right forChronic Hepatitis B Novartis Pharmaceuticals 53
Post-approval studies (Phase 4)UnknownNCT00921180What this trial is testingEntecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis BWho this might be right forHepatitis B, Chronic National Taiwan University Hospital 148
Post-approval studies (Phase 4)UnknownNCT02894918What this trial is testingEvaluate Addition of Peginterferon Alfa-2a to Chronic Hepatitis B (CHB) Patients Treated With NAsWho this might be right forChronic Hepatitis B Henan Provincial People's Hospital 114
Testing effectiveness (Phase 2)Ended earlyNCT02604212What this trial is testingA Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus InfectionWho this might be right forHepatitis B Arrowhead Pharmaceuticals 32
Post-approval studies (Phase 4)UnknownNCT02365402What this trial is testingEfficacies of Entecavir Add on HBeAg Negative Patients With HBV DNA Positive During Peginterferon Alpha 2a TreatmentWho this might be right forChronic Hepatitis B Beijing Ditan Hospital 180
Testing effectiveness (Phase 2)Study completedNCT00804622What this trial is testingEffects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)Who this might be right forChronic Hepatitis B The University of Hong Kong 15
Testing effectiveness (Phase 2)Study completedNCT00034359What this trial is testingSafety and Antiviral Activity Study of ACH-126,443 (Beta-L-Fd4C) in Treatment-naive Adults With Chronic Hepatitis B Virus InfectionWho this might be right forHepatitis B, Chronic Alexion Pharmaceuticals, Inc. 79
Post-approval studies (Phase 4)UnknownNCT01906580What this trial is testingCombination or Sequential Therapy of Peginterferon Alfa-2a and Entecavir for Patients With Chronic Hepatitis BWho this might be right forChronic Hepatitis B Beijing 302 Hospital 105
Not applicableStudy completedNCT01623778What this trial is testingOptimization of Antiviral Therapy of Chronic HBV InfectionWho this might be right forAustralia Antigen PositiveHepatitis BAdverse Effects Changhai Hospital 67
Post-approval studies (Phase 4)UnknownNCT02368288What this trial is testingEfficacies of Entecavir Add on HBeAg Positive Patients With HBV DNA Positive During Peginterferon Alpha 2a TreatmentWho this might be right forChronic Hepatitis B Beijing Ditan Hospital 200
Not applicableStudy completedNCT01645969What this trial is testingA Follow-Up Study of Patients With HBeAg Positive Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML22265Who this might be right forHepatitis B, Chronic Hoffmann-La Roche 65
Testing effectiveness (Phase 2)Ended earlyNCT00964665What this trial is testingPharmacokinetic/Pharmacodynamic of Albinterferon Alfa-2b in Chronic Hepatitis B, eAg+, Infection SubjectsWho this might be right forChronic Hepatitis B Novartis Pharmaceuticals 141
Post-approval studies (Phase 4)Study completedNCT02604823What this trial is testingPeginterferon Alfa-2a (Pegasys) in Participants With Hepatitis B E-Antigen (HBeAg)-Positive Chronic Hepatitis B Virus (HBV)Who this might be right forHepatitis B, Chronic Hoffmann-La Roche 307
Large-scale testing (Phase 3)Study completedNCT02263079What this trial is testingPegylated Interferon Alfa-2A in Combination With Lamivudine or Entecavir Compared With Untreated Control Group in Children With Hepatitis B Envelope Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) in the Immune-Tolerant PhaseWho this might be right forPediatric Immuno-Tolerant Chronic Hepatitis B Hoffmann-La Roche 62